Detalhe da pesquisa
1.
Increased delay from initial concern to diagnosis of autism spectrum disorder and associated health care resource utilization and cost among children aged younger than 6 years in the United States.
J Manag Care Spec Pharm
; 29(4): 378-390, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36989447
2.
Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines.
Hum Vaccin Immunother
; 13(4): 867-876, 2017 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27858509
3.
A Model for Assessing the Clinical and Economic Benefits of Bone-forming Agents for Reducing Fractures in Postmenopausal Women at High, Near-term Risk of Osteoporotic Fracture.
Clin Ther
; 39(7): 1276-1290, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28629610
4.
Denosumab for Elderly Men with Osteoporosis: A Cost-Effectiveness Analysis from the US Payer Perspective.
J Osteoporos
; 2015: 627631, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26783494
5.
Budgetary impact of treating acute promyelocytic leukemia patients with first-line arsenic trioxide and retinoic acid from an Italian payer perspective.
PLoS One
; 10(8): e0134587, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26267454
6.
Cost-Effectiveness Analysis of Treating Acute Promyelocytic Leukemia Patients With Arsenic Trioxide and Retinoic Acid in the United States.
Clin Lymphoma Myeloma Leuk
; 15(12): 771-7, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26361645
7.
Comparison of different adjuvant therapies for 9 resectable cancer types.
Postgrad Med
; 125(2): 83-91, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23816774
8.
Cost effectiveness of denosumab versus oral bisphosphonates for postmenopausal osteoporosis in the US.
Appl Health Econ Health Policy
; 11(5): 485-97, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23868102